Holen Sie sich die Stockscreener-App
1.57
0.32%
0.005
Vorhandelsmarkt:
1.55
-0.02
-1.27%
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
27.30%
0.1181
|
0.1625 | 0.2058 | 0.3546 | 0.5616 |
| Operating Expenses |
17.47%
3.5059
|
4.248 | 3.4319 | 4.4516 | 4.4085 |
| Benefits Costs and Expenses |
18.02%
3.357
|
4.0951 | 3.1006 | 4.1384 | 4.0316 |
| Costs And Expenses |
17.47%
3.5059
|
4.248 | 3.4319 | 4.4516 | 4.4085 |
| Operating Income/Loss |
17.08%
-3.3878
|
-4.0856 | -3.226 | -4.097 | -3.8469 |
| Income/Loss From Continuing Operations Before Tax |
17.64%
-3.2389
|
-3.9327 | -2.8948 | -3.7838 | -3.4701 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
17.64%
-3.2389
|
-3.9327 | -2.8948 | -3.7838 | -3.4701 |
Net Income/Loss
|
17.64%
-3.2389
|
-3.9327 | -2.8948 | -3.7838 | -3.4701 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.49%
6.0833
|
5.9939 | 0.1493 | 5.9398 | 5.9373 |
| Diluted Average Shares |
1.49%
6.0833
|
5.9939 | 0.1493 | 5.9398 | 5.9373 |
| Basic Earnings Per Share |
19.70%
-0.53
|
-0.66 | -0.47 | -0.64 | -0.58 |
| Diluted Earnings Per Share |
19.70%
-0.53
|
-0.66 | -0.57 | -0.64 | -0.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):